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ABSTRACT
The yeast split-ubiquitin system has previously been
shown to be suitable to detect protein interactions
of membrane proteins and of transcription factors
in vivo. Therefore, this technology complements
the classical split-transcription factor based yeast
two-hybrid system (Y2H). Success or failure of the
Y2H depends primarily on the ability to avoid false-
negative and false-positive hits that become a
limiting factor for the value of the system, especially
in large scale proteomic analyses. We provide here
a systematic assessment of parameters to help
improving the quality of split-ubiquitin cDNA-library
screenings. We experimentally defined the optimal
5-fluoroorotic acid (5-FOA) concentration as a key
parameter to increase the reproducibility of inter-
actions and, at the same time, to keep non-specific
background growth low. Furthermore, we show that
the efficacy of the 5-FOA selection is modulated by
the plating density of the yeast clones. Moreover,
a reporter-specific class of false-positive hits was
identified, and a simple phenotypic assay for
efficient de-selection was developed. We demon-
strate the application of this improved system to
identify novel interacting proteins of the human
Frizzled 1 receptor. We identified several novel
interactors with components of the Wnt-Frizzled
signalling pathways and discuss their potential roles
as direct mediators of Frizzled receptor signalling.
The present work is the first example of a split-
ubiquitin interaction screen using an in-situ
expressed receptor of the serpentine class, empha-
sizing the suitability of the described improvements
in the screening protocol.
INTRODUCTION
The development of the yeast two-hybrid technology
(Y2H) by Fields and Song (1) was a milestone in the
analysis of protein interactions. It allowed for the ﬁrst
time the testing of protein interactions in living cells, and it
is suitable for proteome-wide analyses of protein networks
by using selectable reporter genes (2–5).
However, a major limitation of the Y2H system is that
the protein–protein interaction under investigation has to
be reproduced in the yeast nucleus, since it relies on the
reconstitution of a transcription factor split into its DNA
binding and activation domains. This limits the Y2H
interaction studies e.g. of membrane proteins that have to
be ﬁrst truncated to soluble fractions, and frequently
excludes screens with transcription factors that contain
transactivation domains active in yeast.
The yeast split-ubiquitin system has been developed
to overcome the limitations of the classical Y2H system
(6–9): The basic principle of this method is shown in
Figure 1. The system represents a fragment complementa-
tion assay using the ubiquitin molecule split into C- and
N-terminal halves (termed Cub and Nub, respectively) as
interaction sensor. The bait protein of interest is fused
as an N-terminal fusion to Cub, and the prey protein is
expressed as either an N- or C-terminal fusion to Nub. The
interaction of bait and prey protein forces the ubiquitin
halves into close proximity. This results in the formation
of a quasi-native ubiquitin, and triggers the proteolytic
cleavage of the R-URA3p reporter molecule attached
to the C-terminus of Cub by ubiquitin-speciﬁc proteases
(UBPs), followed by proteolytic degradation of the
now N-terminally destabilized URA3p (R-URA3p). As
a consequence, the yeast cells loose their capability to
grow in the absence of uracil, and thus permits negative
selection in the presence of the otherwise toxic URA3p-
speciﬁc antimetabolite 5-ﬂuoroorotic acid (5-FOA).
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the classical Y2H reporter system is that it does neither
depend on nuclear translocation of the complex compo-
nents nor on a transcriptional readout. Consequently,
the R-URA3p based split-ubiquitin system can detect
interactions at their natural site (in situ), e.g. at or in the
membrane (9). It also facilitates the use of transcription
factors as bait proteins (10). In contrast, a distinct variant
of the split-ubiquitin system uses a transcription factor
readout is restricted to the test of membrane-based
protein interactions (and is therefore frequently termed
‘membrane-based Y2H’) (7). The high degree of sensitivity
of the R-URA3p-based split-ubiquitin interaction system
was recently documented through its use in a small-
molecule—protein interaction system for drug discovery
research (a split-ubiquitin—based yeast three-hybrid
system) (11).
The success of the classical Y2H application in the
past has relied strongly on methodological improvements
particularly for large scale protein–protein interaction
approaches. These improvements essentially aimed at
increasing both the speed and the accuracy of the Y2H
system: For instance, a signiﬁcantly increased throughput
could be achieved by the introduction of the interaction-
mating approach instead of the various, less eﬃcient and
more laborious, transformation procedures to obtain bait-
and prey-plasmid bearing yeast clones for the subsequent
reporter assays (12,13). However, to obtain high ﬁdelity
in interpreting results from large scale interaction screens,
the appearance of Y2H - intrinsic classes of false-positive
and false-negative hits needs to be understood and subse-
quently reduced. Proteins with broad interaction capabil-
ities represent one important class of false-positive hits,
and can be speciﬁc for the version of the employed Y2H
system (i.e. the split-transcription factor and the reporter
version used). A fast and eﬃcient way to sort out such
false-positives is the use of the so-called dual-bait strategy
(14). In this setup, a given prey protein is tested simulta-
neously against the actual and any unrelated bait within a
single cell by employing diﬀerent DNA-binding elements
for the two baits combined with separate reporter genes.
Here we present a rationale to control the false-negative
and false positive-rates in split-ubiquitin protein–protein
interaction screens that use the R-URA3p reporter system.
For this purpose, we used our past experience of more than
35 independent screenings employing a variety of diﬀerent
baits, and an established split-ubiquitin protein–protein
interaction pair (p53–protein phosphatase 5) to ﬁne-tune
parameters of an optimized cDNA-library screening
system. This way, we were able to identify the 5-FOA
concentration as a critical parameter that allows control-
ling the rates of false-negative and false-positive interac-
tion candidates. We experimentally deﬁne the optimal
5-FOA concentration, and demonstrate that it correlates
to the plating density. Furthermore, we identiﬁed an
R-URA3p reporter-speciﬁc class of false-positive hits, and
present solutions to eliminate them by a simple and fast
phenotypic assay.
We demonstrate the eﬃcacy of this optimized split-
ubiquitin cDNA-library screening protocol to ﬁnd inter-
actors of the human Frizzled 1 receptor. Frizzled (Fz)
receptors share the structural organization of G protein-
coupled receptors (GPCRs) and are comprised of
seven transmembrane spanning domains, a complex
N-glycosylated exofacial N-terminal region, and a cyto-
plasmic C-terminal tail. These receptors are activated
through binding to ligands called Wnts, which are secreted
lipid-modiﬁed signalling proteins. Wnt-Fz mediated
signalling controls cell polarity, embryonic induction,
speciﬁcation of cell fate and moreover is thought to play
a role in diseases such as cancer, osteoporosis and
psychiatric disorders (15,16).
Wnt-Fz signaling has been classiﬁed into so called
canonical (b-catenin dependent) and noncanonical
(b-catenin independent) pathways (17–19). While the
signalling components of canonical signalling are diver-
gent from classical GPCR signal transduction, there are
common features with non-canonical signalling. This
includes e.g. sensitivity of Wnt-stimulated calcium ﬂux
and other signalling events to pertussis toxin (PTX), a
speciﬁc inhibitor of G proteins of the Gi-class. However,
direct intracellular mediators of both canonical and non-
canonical Frizzled signalling have not yet been clearly
deﬁned. So far this precluded to classify b-catenin-
independent signalling events into discrete pathways.
Using this optimized split-ubiquitin cDNA-library
screening system, we describe the identiﬁcation of novel
interacting proteins of the human Fz1 receptor, which is
a prototypical inducer of the canonical pathway (20,21).
Several of these, or their respective homologs, were
previously reported to interact physically and/or function-
ally with known components of Wnt-Fz signalling path-
ways, independently validating our screening strategy.
MATERIALS AND METHODS
E.coli and yeast strains
All plasmid constructions and ampliﬁcations were per-
formed using the E. coli strain XL1-Blue (Stratagene).
The yeast strain used for the split-ubiquitin assays was
JD53 MATa his3-D200 leu2-3,112 lys2-801 trp1-D63
Figure 1. Principle of the yeast R-URA3p-based split-ubiquitin
protein–protein interaction system. The interaction of bait and prey
proteins leads to the reconstitution of ubiquitin, resulting in proteolytic
degradation of the R-URA3p reporter molecule. This renders the yeast
cells URA-auxotroph and resistant to 5-FOA. See text for details.
UBPs, ubiquitin speciﬁc proteases.
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analysis the yeast strain MH272-1da MATa his3 leu2-
3,112 ura3-52 trp1 rme1 HMLa (23) was used.
Plasmid constructs
All bait constructs are based on the previously described
vector pPcup1-ubc9-CRU (11), which is a low copy yeast–
E. coli shuttle vector that carries a Cub-R-URA3 cassette
(CRU), a copper-dependent promoter (PCUP1) for bait
expression, and a HIS3 marker. All constructs were veri-
ﬁed by sequencing. The human Fz1-derived bait con-
structs are depicted schematically in Fig. 5.
pPCUP1-Fz1-CRU. This construct is based on the previ-
ously described vector pPCUP1-ubc9-CRU (11), which
is a low copy yeast–E. coli shuttle vector that carries a
CRU, a copper-dependent promoter (PCUP1) for bait
expression, and a HIS3 marker. The human Fz1 coding
sequence was ampliﬁed by PCR from a human whole
brain cDNA preparation (Clontech) using primers
Fz1-FW (50-AATTGTCGACATGGCTGAGGAGGAG
GCGCCTAAG-30) and Fz1-RV (50-AGCGGCCGCGA
CTGTAGTCTCCCCTTGTTTGC-30), introducing SalI
and NotI restriction sites, respectively. The Fz1 PCR
product was eventually used to replace the Ubc9 insert in
pPCUP1-ubc9-CRU using SalI-NotI restriction sites,
resulting in pPCUP1-Fz1-CRU.
pPCUP1-Fz1-C-tail-CRU. Primers tail-FW (50-AATTGTC
GACATGTGGATCTGGTCCGGCAAG-30), introduc-
ing SalI and a start codon, and Fz1-RV (see above)
were used to amplify the 30-terminal 87bp of the Fz1
coding sequence from pPCUP1-Fz1-CRU by PCR. The
Fz1-C-tail PCR product was eventually used to replace
the ubc9 insert in pPCUP1-ubc9-CRU using SalI-NotI
restriction sites, resulting in pPCUP1-Fz1-C-tail-CRU.
pPCUP1-Fz1-CRD-CRU. Primers CRD-FW (50-AATTGT
CGACATGGACCACGGCTATTGCCAG-30), introduc-
ing SalI and a start codon, and CRD-RV (50-AGCGG
CCGCCCAAATGCCAATCCAGGTGC-30), introducing
NotI, were used to amplify a fragment of 645bp covering
the cysteine-rich-domain of Fz1 including the downstream
portion seizing the predicted ﬁrst helix from
pPCUP1-Fz1-CRU by PCR. The resulting Fz1-CRD
PCR product was eventually used to replace the ubc9
insert in pPCUP1-ubc9-CRU using SalI-NotI restriction
sites, resulting in pPCUP1-Fz1-CRD-CRU.
pPCUP1-s-Fz1-CRU. The 50 138bp of the Saccharomyces
cerevisiae Ste2 coding sequence (termed ‘s’ for signal
sequence), comprising the receptor’s complete N-terminal
extracellular tail, were ampliﬁed from a yeast genomic
DNA preparation using primers Ste2-FW (50-AATTG
TCGACATGTCTGATGCGGCTCCTTC-30), introduc-
ing SalI, and Ste2-RV (50-GTACTGTTAACTAAACC
TTG–30), introducing a HpaI site. Human Fz1 cDNA
lacking the 50 333bp of the coding sequence, comprising
the region upstream of the receptor’s cysteine rich domain
(CRD), was ampliﬁed from pPCUP1-Fz1-CRU using
primers Fz1-HpaI (50-ATATGTTAACGACCACGGCT
ATTGCCAGCC-30), introducing HpaI, and Fz1-RV.
In a triple ligation set up, SalI-HpaI restricted Ste2 frag-
ment and HpaI-NotI restricted Fz1 fragment were used to
replace the ubc9 insert in PCUP1-ubc9-CRU using SalI-
NotI restriction sites, resulting in pPCUP1-s-Fz1-CRU.
pPCUP1-p53-CRU. This bait construct encoding the full
length human p53 gene was cloned via SalI-NotI in an
analogous way to the constructs described above, and was
kindly provided by GPC Biotech AG (Munich).
pPADH-NubI-PP5. Full length human protein phospha-
tase 5 was identiﬁed as a p53 interactor in a previous split-
ubiquitin screen performed at GPC Biotech AG (Munich)
using above described pPCUP1-p53-CRU bait construct in
a human fetal brain NubI-split-ubiquitin cDNA-library
(see below).
pYES2-s-Fz1-myc. The s-Fz1 fusion gene was ampliﬁed
by PCR from pPCUP1-s-Fz1-CRU using primers DD-11
(50-ATAAGCTTATGGCTGAGGAGGAGGCGCC-30)
and DD-12 (50-TAGGATCCCTACAGATCCTCTTCTG
AGATGAGTTTTTGTTCGACTGTAGTCTCCCCTT
GTTTG-30), introducing a HindIII site, a C-terminal
c-myc-tag followed by a STOP codon, and a BamHI site,
respectively. The HindIII-BamHI digested s-Fz1-myc
fragment was ligated to HindIII-BamHI restricted yeast
expression vector pYES2 (Invitrogen), resulting in
pYES2-s-Fz1-myc.
pYES2-s-Fz1-GFP. The s-Fz1 fusion gene was ampli-
ﬁed by PCR from pPCUP1-s-Fz1-CRU using primers
DD-13 (50-ATAAGCTTATGTCTGATGCGGCTCCTT
CATTG-30) and DD-18 (50-TAGAATTCGACTGTAGT
CTCCCCTTGTTTG-30) introducing HindIII and EcoRI
sites, respectively. Enhanced green ﬂuorescent protein
(eGFP) was ampliﬁed by PCR from pEGFP-C1
(Clontech) using primers DD-19 (50-ATGAATTCGTGA
GCAAGGGCGAGGAGC-30) and DD-20 (50-TAGGA
TCCTTACTTGTACAGCTCGTCCATGC-30), introduc-
ing EcoRI and BamHI sites, respectively. HindIII-EcoRI
digested s-Fz1 and EcoRI-BamHI digested eGFP frag-
ments were ligated to HindIII-BamHI restricted yeast
expression vector pYES2 (Invitrogen), resulting in
pYES2-s-Fz1-GFP.
pGEX-p53. The p53-cDNA was excised via Sal-NotI from
pPCUP1-p53-CRU, and ligated to SalI-NotI-restricted
pGEX-4T-3 (Amersham Biosciences), resulting in
pGEX-p53.
pASK-PP5. The full length cDNA of human protein
phosphatase 5 was ampliﬁed by PCR from pPADH-NubI-
PP5 using primers PP5-FW(50-ATGAATTCGCGATGG
CGGAGGGCGAGAGGACT-30) and PP5-RV(50-AT
CTCGAGCATTCCTAGCTGCAGCAGCGTGTTG-30),
introducing EcoRI and XhoI sites respectively, and ligated
to EcoRI-XhoI restricted pASK-IBA5plus (IBA GmbH,
Goettingen), resulting in pASK-PP5.
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Yeast strain MH272-1da (23), transformed with pYES2-
s-Fz1-myc or with the empty vector pYES2, was cultivated
in 50ml SD-U medium to the exponential growth phase.
To induce protein expression, the cultures were transferred
to galactose-containing minimal medium for 5h. Cells
were pelleted and resuspended in 300ml lysis buﬀer
(100mM Tris–HCl pH 8.0, 20% glycerol, 1% Triton
X-100, 1mM dithiothreitol, 1mM phenylmethylsulpho-
nylﬂuoride). Cells were disrupted by vortexing at 48C for
10min following addition of acid-washed glass beads
(0.45mm diameter). The crude protein extract was cleared
by centrifugation at 3000 g for 5min. The protein
concentration was determined using the Biorad protein
assay (Biorad, Munich). The extract of 20mg were electro-
phoresed using a 4–12% gradient NuPAGE Bis–Tris gel
system (Invitrogen, Karlsruhe). The proteins were electro-
blotted to a nitrocellulose membrane. The membrane
was blocked in Tris-buﬀered saline (TBS, 0.1% Tween 20)
containing 5% non-fat dry milk, and subsequently incu-
bated with a mouse anti-c-myc monoclonal antibody
conjugated to peroxidase (Roche, Basel) at a 1:1000 dilu-
tionin TBS, 0.1%Tween 20, 1% bovine serum albumin for
1h at room temperature. Detection was performed using
the Immune-Star HRP substrate kit (Biorad, Munich) and
Hyperﬁlm (Amersham Biosciences, Freiburg).
Glutathione S-transferase (GST) pull-down experiment
The preparation of the GST-p53 fusion-protein coupled
to glutathione-agarose was performed according to the
manufacturer’s instructions for the GST gene fusion
system (Amersham Biosciences): In brief, E. coli expres-
sion strain BL21 was transformed with pGEX-p53.
Protein expression in an exponentially growing culture
in 2YT medium (400ml) including ampicillin was induced
over 2h by adding IPTG (0.1mM). Eventually, the cells
were harvested by centrifugation at 48C, and resuspended
in 20ml phosphate-buﬀered saline (PBS) containing a
protease inhibitor cocktail (Sigma). Cells were disinte-
grated by sonication under cooling, and the lysate was
cleared by centrifugation at 10.000 ga t4 8C for 10min.
Fifty percent of 400ml GSH-agarose (Sigma) were added
to the sonicate, and incubated with gentle agitation at
room temperature. Subsequently, the GSH-agarose was
pelleted by centrifuging for 5min at 500 g, and washed
three times with 10ml PBS at 48C.
The puriﬁcation of the Strep-tagged PP5 protein was
performed according to the manufacture’s instructions
for the Strep-Tactin aﬃnity tag system (IBA GmbH,
Goettingen): In brief, E. coli expression strain BL21 was
transformed with pASK-PP5. Protein expression in an
exponentially growing culture in 2YT medium (100ml)
including ampicillin was induced over 2h by adding
anhydrotetracycline (200mg l). Eventually, the cells were
harvested by centrifugation at 48C, and resuspended in
5ml ice-cold 100mM Tris-HCl pH8.0, 1mM EDTA
containing a protease inhibitor cocktail (Sigma). Cells
were disintegrated by sonication under cooling, and the
lysate was cleared by centrifugation at 10.000 ga t4 8C
for 10min. The cleared lysate of 5ml were applied to a
streptactin-sepharose column (1ml bed volume) equili-
brated with 100mM Tris–HCl pH8.0, 1mM EDTA. The
column was eventually washed ﬁve times with 500ml
 1
100mM Tris-HCl pH8.0, 1mM EDTA. Elution of the
bound protein was performed using six times 500ml
100mM Tris-HCl pH8.0, 1mM EDTA containing
2.5mM desthiobiotin, and the eluates were pooled.
GST-p53, or GST-loaded GSH-agarose of 100ml
(prepared from BL21 transformed with pGEX as control)
were washed two times with 1ml 100mM Tris–HCl
pH8.0, 1mM EDTA, and eventually incubated each
with 1ml Strep-PP5 containing eluate, and incubated at
48C for 1h. At the end of the incubation, the beads were
settled by gravity, and the supernatant was collected as the
unbound fraction. The resin was extensively washed with
100mM Tris–HCl pH8.0, 1mM EDTA, and subsequently
eluted with the addition of 1ml SDS-containing
sample loading buﬀer, representing the bound fraction.
Corresponding aliquots of Strep-PP5 containing eluate
(‘input’-fraction), ‘unbound’ and ‘bound’ fractions were
electrophoresed using a 12% SDS-PAGE gel system.
The proteins were electroblotted to a nitrocellulose
membrane. The membrane was blocked in 3% non-fat
dry milk in 1 PBS, 0.1% Tween 20 (Sigma) for 1h at
room temperature. Eventually, the membrane was incu-
bated with a Strep-Tactin-HRP conjugate (IBA GmbH,
Goettingen) diluted 1:100000 in PBS, 0.1% Tween 20
for 1h. Detection was performed using the Immune-Star
HRP substrate kit (Biorad, Munich) and Hyperﬁlm
(Amersham Biosciences, Freiburg). Eventually, the mem-
brane was blocked again, and redetected using anti-GST-
POD conjugate (Sigma) diluted 1:20000 in 1 PBS,
0.1% Tween. Purity and integrity of the GST-p53 and
Strep-PP5 fusion proteins were monitored using silver-
stained SDS-PAGE gels (data not shown).
Confocal microscopy
Microscopic inspection of agarose-embedded s-Fz1-GFP
expressing yeast strain MH272-1da (23) following
galactose-induction was performed using a Zeiss LSM
510 META confocal microscope.
Survival assays using thep53-PP5 model proteininteraction
The survival assays were carried out by a procedure
analogous to the actual cDNA-library screens described in
the appendix section of this article. In brief, yeast strain
JD53 was sequentially co-transformed with plasmids as
indicated in the ‘Results’ section using a high-eﬃciency
transformation procedure (24). Plating at a density of
 600 co-transformants/cm
2 medium area (standard
screening plating density) was performed onto large
screening dishes (Nunc 22.5 22.5cm BioAssay Dish),
containing either SD-LEU-HIS medium, or SD-LEU-
HIS, 100mM Cu2SO4, with 5-FOA concentrations as
indicated in the ‘Results’ section. The evaluation was done
as described in the ‘Results’ section.
Human fetal brain NubI split-ubiquitin cDNA-library
The employed human fetal brain NubI—split ubiquitin
cDNA library was kindly provided by GPC Biotech
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Split-ubiquitin prey expression vectors are based on
plasmid PADNS (25), and are derivatives of PADNX-
Nub-BC plasmids as previously described (10). These
plasmids carry 2m origins, ampicillin resistance genes and
the wildtype N-terminal part of ubiquitin (NubI) (6) driven
by an ADH promoter. pPADH-NubI contains unique SalI
and NotI restriction sites in the multiple cloning site
(MCS) followed by stop codons in all three reading
frames.
Total human fetal brain poly(A)+ RNA was purchased
from Clontech (St-Germain-en-Laye), and cDNA syn-
thesis was performed using poly (T)-primers introducing
a NotI restriction site. After second strand synthesis,
a SalI adapter ligation was performed, followed by NotI
digestion and cDNA size-fractionation chromatography.
Individual ligation set ups of resulting diﬀerent cDNA
fractions to each of the three diﬀerent frame versions of
SalI-NotI restricted pPADH-NubI prey vector were per-
formed. Following small scale E. coli (DH10B, Gibco)
electroporation with aliquots of individual ligation reac-
tions, size distribution of cDNA inserts was monitored
using PCR. Eventually, fractions were pooled to cover a
size distribution ranging from  500 to 3000bp, and ﬁnally
a total of  1 10E6 independent clones was generated,
from which plasmid maxi—preparations were performed
(Qiagen, Hilden).
Optimized split-ubiquitin cDNA-library screening procedure
A detailed experimental protocol is provided in the
Supplementary section of this article, and is schematically
represented in Figure 2.
RESULTS
We set out to deﬁne generally applicable conditions to
minimize both false-negative and false-positive hits in
the split-ubiquitin cDNA-library screening system based
on the R-URA3p reporter (9) (Figure 1). We found that
variations of two parameters that are interdependent
strongly aﬀect the quality of the screening results: (i) The
optimal 5-FOA concentration used for selecting interac-
tion pairs, (ii) the plating density of the transformations
that, in turn, aﬀects the 5-FOA selection pressure. We
determined optimal conditions for both parameters and
tested these in an interaction screening assay using the
human Fz1 receptor that in the past has been shown to be
not suitable for Y2H interactor analyses. We ﬁnd that the
resulting workﬂow of our improved screening protocol
(Figure 2) is generally applicable and has, in the mean-
time, been successfully used in >35 interactor screens.
Furthermore, we proved experimental details in the
‘Material and Methods’ and the Supplementary sections
accompanying this article to facilitate the general applica-
tion of the protocol.
Definition ofthe optimal 5-FOAconcentration for
split-ubiquitin cDNA-library screens as akey
parameter tocontrol thehit rate
In the many screens we performed so far with distinct bait
constructs, the 5-FOA concentration used in the selection
strategy strongly aﬀected the ratio of 5-FOA resistant
clones compared to the total number of screened yeast
clones (We will term this ratio ‘survival rate’ in the
following text). It also aﬀected the rate of false-positive
hits, which are deﬁned as bait-prey interactions that
cannot be reproduced in an independent retesting using
the split-ubiquitin system. In general, increasing the
5-FOA concentration from 0.5 to 1.0g per liter of
medium led to survival rates that were reduced by at
least one order of magnitude (typically from 1:30000
down to 1:500000).
Surprisingly, the false-positive rate increased gener-
ally up to >95% at 5-FOA concentrations above 0.8gl
 1,
whereas one would intuitively suggest that the reduced
survival rate would result in a higher speciﬁcity and
a reduced number of false-positives. Analyses of these
5-FOA resistant clones revealed that they contained
mutated bait plasmids with an apparently defective
R-URA3 reporter cassette. This was indicated by the
absence of any growth on medium lacking uracil, paral-
leled by 5-FOA resistance that is not conferred by
any prey plasmid in the re-tests (for an example see
Figure 7).
We reasoned that this enrichment of URA3-negative
clones at higher 5-FOA concentrations may be the result
of a higher 5-FOA tolerance as those clones that express
interacting bait and prey combinations. To test this
systematically we compared the survival rates of clones
expressing an inactive URA3p with clones expressing
interacting bait-prey combinations at diﬀerent 5-FOA-
concentrations. For this experiment we chose the human
tumor suppressor gene p53 as bait protein (p53-CRU) and
human protein phosphatase 5 (PP5) as prey (NubI-PP5).
Figure 2. Optimized ﬂowchart for split-ubiquitin protein-protein inter-
action cDNA-library screens. See text for details.
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acterized in a previous screen (Figure 3). Indeed, clones
bearing only the inactive URA3-cassette, but no bait/prey
combinations, showed a considerably higher 5-FOA toler-
ance (IC50 5-FOA: >1.0g
 1l; inhibitory 5-FOA concen-
tration resulting in a survival rate of 50%) than clones
expressing the strongly interacting p53-PP5 combination,
(IC50 5-FOA:  0.5gl
 1) (Figure 4). Consistently, URA3-
negative clones grew better to become signiﬁcantly larger
colonies than the p53-PP5 interaction clones on screening
agar plates. An equivalent observation was also made in
the patch growth assay.
We conclude that there is a residual URA3p-activity
that generates a background even in those clones in which
an interaction occurs. This, in turn, results in a consider-
able increase in 5-FOA sensitivity that is even higher than
that seen in clones that, due to mutations or contamina-
tions, lack a functional URA-3 gene. From this experi-
ment we strongly suggest to not exceed an optimal 5-FOA
concentration of 0.5gl
 1. Above this threshold concentra-
tion, the chances to isolate valid interactions decrease
strongly. As a cause we identiﬁed an enrichment of false-
positive clones resulting from URA3 inactivation that is
independent of the N-end rule degradation of URA3 as
a consequence of ubiquitin reconstitution via bait-prey
interactions. In the Fz1 interaction screen shown below we
describe a simple and rapid method to phenotypically sort
out this class of false-positives.
In order to experimentally deﬁne the minimal 5-FOA
concentration required to suppress non-speciﬁc back-
ground growth, we tested the combination of a plasmid
bearing p53-CRU and the empty NubI-prey plasmid in the
5-FOA tolerance assay to mimick the absence of p53
interaction. As expected, tolerance of these clones for
5-FOA was lower than the other combinations tested
(IC50 5-FOA  0.3gl
 1). This suggests a minimal 5-FOA
concentration of  0.4gl
 1 at which most background
growth is suppressed (Figure 4). We found equivalent
minimal 5-FOA concentrations to be useful in a variety of
bait constructs not related to p53, such as the yeast
proteins Mrs6p, Sec16p and Sec63p (data not shown).
In conclusion, we have deﬁned experimentally an optimal
5-FOA concentration of 0.5gl
 1 at which a balance
between the maximal growth of interaction clones and a
tolerable non-speciﬁc background growth coexists.
Yeast platingdensity affects theselection pressure by 5-FOA
We found another critical property of the R-URA3p
reporter that is modulated by the yeast transformation
protocol of the libraries. We observed in various screens
that the 5-FOA survival rates of clones harboring inter-
acting bait/prey combinations strongly depend on their
plating density (deﬁned as number of co-transformants
Figure 3. Interaction of human p53 and protein phosphatase 5 (PP5). (A) Split-ubiquitin interaction assay. Clones expressing p53 (p53-CRU bait
construct) and PP5 (Nub-PP5 prey) were spotted in serial dilutions onto medium lacking uracil (-URA), medium containing 5FOA (+FOA), and
control plates selective for the presence of plasmids (C). Interaction is indicated by lack of growth on -URA, paralleled by 5-FOA resistance. A clone
co-transformed with p53 and empty prey vector (NubI) served as negative control. A previously identiﬁed bait construct with an inactive URA3p
phenocopying a true interaction event was also included. (B) GST-pull down experiment. Puriﬁed Strep-tagged PP5 (Strep-PP5) expressed from
E. coli was incubated with GSH-agarose beads loaded with E. coli expressed GST-p53 fusion protein, or GST alone. Corresponding aliquots of
Strep-PP5 ‘input’, ‘unbound’ and ‘bound’ fractions were electrophoresed using SDS-PAGE, and electroblotted to nitrocellulose. Detection was
performed ﬁrst by using a Strep-tactin-HRP conjugate, followed by redetection using an a-GST-HRP conjugate. The asterisk indicates the speciﬁc
signal.
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Figure 4. Diﬀerential 5-FOA tolerance for yeasts expressing interactors
and after mutational loss of R-URA3p. Clones expressing interacting
p53 (bait)-PP5 (prey), p53 and empty Nub-prey-vector (no interaction),
or an inactive URA3p (false-positive) were plated at the standard
plating density ( 600 co-transformants/cm
2 medium) on SD-HIS-URA
(transformation control plate) and on 5-FOA (as indicated). Relative
5-FOA tolerance levels were calculated as the ratio of emerging 5-FOA
resistant clones with respect to the control plate (survival rate in %).
Data represent the mean of two independent experiments +/  range.
The grey area indicates the range of 5-FOA concentrations found
optimal for the screens.
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2 medium area), which is a variable of the trans-
formation eﬃciency. In order to demonstrate this relation-
ship systematically, we devised additional 5-FOA tolerance
experiments: For this purpose, we again used the p53-PP5
model interaction and kept the 5-FOA concentration
constant at the optimal rate of 0.5gl
 1 as described
above. Instead, we reduced the plating density from 600
co-transformants per cm
2 medium area (corresponding
to our standard transformation protocol, as used above)
down to 60 by a 10-fold dilution of the transformation
mixture. Surprisingly, we observed a dramatically reduced
survival rate from approximately 60% down to 10%
(data not shown). We suggest that a decreased number
of transformants expressing URA3p may result in an
increased ratio of 5-FOA molecules per cell. This exerts a
stronger selective pressure, and consequently results in
lowered survival rates. Based on these results, we suggest
a 5-FOA concentration of 0.5gl
 1 as optimal for a plating
density of 600–900 transformants/cm
2. Our experiments
also showed that lowering the plating density through
low-eﬃciency transformation methods (e.g. by double
transformations of bait and library instead of a sequential
transformation as used here; see ‘Supplementary Data’)
results in too stringent selection conditions, probably as
a result of a local excess of 5-FOA. As a consequence,
URA3-negative clones will have a growth advantage and
will be enriched (data not shown). On the other hand,
we found that considerably higher plating densities (>2000
co-transformants per cm
2 medium area, which can be
achieved using yeast mating protocols) yield unwanted
interaction—independent background growth due to a
lowered ratio of 5-FOA molecules per cell (data not
shown).
In conclusion, we suggest to ﬁrst deﬁne transformation
eﬃciencies for any new bait/library screenings. Based on
the resulting plating density, the optimal 5-FOA concen-
tration that allows maximal survival of interaction events
and, at the same time, minimizes non-speciﬁc background
growth, should be determined individually.
Split-ubiquitin NubI-humanfetal brain cDNA-library
screen using thehuman Frizzled 1receptor asbait
Using the parameters deﬁned above, we performed a split-
ubiquitin interactor screen using a NubI-human fetal brain
cDNA-library and the human Fz1 receptor as bait. We
reasoned that a screen using this bait that in the past
proved to be non-accessible for standard Y2H screenings
may serve as a stringent control for the quality of the
protocol. The chart depicting the screening workﬂow that
is generally applicable is shown in Figure 2.
Cloning of baits. A simple growth assay to determine bait
expression. We used the full length cDNA of human Fz1
to construct the pPCUP1-Fz1-CRU bait expression vector
(Figure 5A) in which the Fz1 cDNA is expressed as a
translational fusion to the URA3 gene. We reasoned that
the generation of URA3p could be used as an indicator
for Fz1 expression. In order to verify solid expression
of this construct, we therefore tested URA3p levels in
a growth assay. Surprisingly, the transformants with
pPCUP1-Fz1-CRU did not grow on minimal media lack-
ing uracil (100mMC u
2+ for induction, used as standard
concentration). This immediately prevented the use of
this construct in our split-ubiquitin interaction assays
(Figure 5A). Whereas most bait constructs in our hands
required a standard copper ion concentration of 100mM
for induction, some baits were fully expressed only upon
addition of up to 200mMC u
2+. In the case of pPCUP1-
Fz1-CRU, however, copper concentrations >200mM were
not eﬀective (data not shown). We have observed similar
diﬃculties with only six other bait constructs not related
to Fz1, representing <20% of all tested proteins. These
included CHIP (a cytosolic E3/E4 ligase), PINK1
(a Parkinson’s Disease associated kinase with predomi-
nantly mitochondrial localization), the Ret protooncogene
(a transmembrane receptor) and inversin (a cytosolic
component of the Wnt signalling pathway). A correlation
between the particular cellular localization of these
proteins and expression problems could not be detected.
Figure 5. Schematic overview of tested Frizzled 1 bait constructs and expression tests. (A) Full-length Frizzled (pPCUP1-Fz1-CRU) as well as
respective deletion constructs (pPCUP1-Fz1-CRD-CRU and pPCUP1-Fz1-C-tail-CRU), and N-terminal fusion of the Ste2N-terminal tail (termed ‘s’)
to Fz1 (pPCUP1-s-Fz1-CRU) are represented. The position of the cysteine-rich domain (CRD) and predicted transmembrane regions (shaded boxes)
are indicated. Expression of the bait constructs is shown by growth (+/ ) on media lacking uracil (-U). Transformation control plates (C) contained
uracil. (B) western blot analysis using s-Fz1-myc expressing yeast cells. Crude protein extracts were prepared and resolved on 4–12% gradient SDS-
PAGE. Detection was performed using an anti-c-myc monoclonal antibody-peroxidase conjugate. Molecular weight standards in kDa are indicated.
Aditional bands visible on the gel may represent glycosylated receptor, a frequent modiﬁcation of serpentine receptors. The control extract was
derived from a yeast strain transformed with the empty expression vector. See ‘Material and Methods’ for details.
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solved by truncating the bait constructs and by choosing
distinct 50 ends. One suggestion is that the 50 ends of some
bait cDNAs, providing the translation initiation sites of
the bait-URA3 constructs, may prevent suﬃcient expres-
sion levels. Another possibility is that some proteins,
in particular membrane proteins, may be improperly
targeted to the yeast secretory pathway.
To distinguish between both possibilities, we selectively
expressed Fz1 receptor truncations that contain domains
which are known, or are predicted to, mediate protein
interactions. Firstly, we expressed the N-terminal cysteine-
rich-domain (CRD), which is characteristic for Frizzled
receptors and has been implicated in Wnt-ligand binding
(26). Secondly, we tested expression of the C-terminus of
the receptor, since this may be critical for contacting
downstream eﬀectors on the cytoplasmic face of the
plasma membrane. For this purpose, pPCUP1-Fz1-CRD-
CRU and PCUP1-Fz1-C-tail-CRU plasmids were con-
structed (Figure 5A). Both constructs resulted in suﬃcient
growth on uracil selective media indicating that this time
suﬃcient amounts of bait proteins were expressed to
use them in subsequent library screenings (Figure 5A).
Although we did not analyze expression problems more
systematically, in the case of F1 the data are consistent
with improper targeting of the full-length clone. In order
to force targeting of Fz1 to the correct subcellular
localization, we designed a chimeric receptor bait, in
which the amino acid sequence upstream of the CRD
domain was replaced with the extracellularly localized,
N-terminal tail of the yeast a-factor receptor Ste2p
(termed ‘s’-sequence in the following). Expression of this
s-Fz1 chimeric receptor complemented uracil auxotrophy,
suggesting that the fusion protein was made in suﬃcient
amounts and that Ura3p obviously interacts with its
cytoplasmically localized substrate orotidine-5’-phosphate
(Figure 5A). This was conﬁrmed in a western blot using
a myc-tagged version of the s-Fz1 receptor where we
obtained a signal of expected size (60kDa) (Figure 5B).
In order to prove the correct subcellular localization
of the s-Fz1 receptor (in the cytoplasmic membrane),
we expressed the bait in a fusion construct with enhanced
green ﬂuorescent protein (eGFP) and monitored the GFP
signal. The protein was localized both at the plasma
membrane and in vesicle-like structures in the cell, com-
parable to the localization described previously for
GFP-tagged Ste2p (27) (Figure 6).
We conclude from these studies that it is necessary,
before performing the library screenings, to verify for
each bait that suﬃcient levels of protein are expressed.
We suggest using the complementation of uracil auxo-
trophy of the bait constructs as a simple test for bait
expression and trying out alternative protein subfrag-
ments, in case the expression of full-length clones fails.
Screening for protein interactors of s-Fz1. We screened
for protein interactors of s-Fz1 using a poly(T)-primed
human fetal brain cDNA-library fused C-terminally to
NubI. We generated approximately 3 10E6 HIS3-LEU2
positive co-transformants, corresponding to 3-fold library
coverage. Using the conditions described above, we
isolated a total of 88 5-FOA resistant clones which corre-
sponds to a survival rate of 1:34090. This was compar-
able to previous split-ubiquitin screens with other baits
performed in our lab.
Elimination of false-positive interaction candidates by
URA3 inactivation. As stated above, one class of false-
positive signals in our split-ubiquitin screens could be
derived from URA3-negative plasmids. We devised a fast
phenotypic test to sort out these candidates prior to more
time-consuming analyses. For this purpose, we ﬁrst tested
whether there exists a correlation of URA-auxotrophy
to the presence of the respective prey plasmid: Clones
that were auxotroph for URA should contain a prey
plasmid, otherwise they are regarded as false-positives.
Random loss of this prey plasmid should result in URA-
prototrophy. Instead of relying on a counter-selectable
marker typically used in classical yeast two-hybrid appli-
cations, our negative selection scheme allowed us to test
URA-auxotrophy following the passive loss of the prey
plasmid.
Figure 6. Confocal micrographs of yeast cells expressing s-Fz1-GFP. Cells were immobilized by agarose-embedding, and the ﬂuorescence signal was
recorded from two diﬀerent planes. s-Fz1-GFP can be detected at the membrane and in intracellular spots that most likely are vesicle-like structures,
similarly to the localization of Ste2p (27). The right panel shows the brightﬁeld view.
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cultured at non-selective conditions to induce passive
prey-plasmid loss, and phenotypic analyses were per-
formed (Figure 7). Accordingly, 63 of 88 clones showed
URA-prototrophy, corresponding to a very low false
positive rate of 28.4%, which was similar to previous
screens performed in our lab. One explanation for this
remaining population may be a constant random muta-
tion rate of the URA3 gene in the various bait strains.
A higher rate of false-positives would have been indicative
of too stringent selection conditions (such as too high
5-FOA concentration, see above). Moreover, contamina-
tion with foreign yeast plasmids without URA3 could also
account for signiﬁcantly higher false-positive rates, and
can easily be identiﬁed using the presented procedure.
Phenotypic re-testings of identified prey plasmids. In our
next selection step we retransformed the remaining
63 clones to test their ability to confer URA-auxotrophy
and 5-FOA resistance. Surprisingly, only 16 clones
showed the expected phenotype (Figure 8), although all
63 clones had behaved correctly in the URA-prototrophy
tests (see above). Based on our previous experience the
relatively large proportion of 75% false-positives is not
unusual. These typically arise from clones picked from
background colony growth. This is the result of the rela-
tively small experimental window for the optimal 5-FOA
concentration to control background growth while, at
the same time, maximizing the survival of interactors
(compare Figure 4).
Analyses of the s-Fz1 prey-data set. The 16
re-transformation positive clones were sequenced, and
peptide sequence database searches were performed
using BLASTx (National Center for Biotechnology
Information—NCBI). The extracted results are shown
in Table 1.
A general observation was that, in all retransformation-
positive clones, cDNA inserts were fused in-frame with the
Nub moiety. In contrast, cDNA inserts derived from
the false-positive fraction contained almost exclusively
50-untranslated regions plus the respective downstream
coding sequence. This demonstrates that the method
provided allows an eﬃcient de-selection of false-positive
clones.
Taken together, we provide a combination of improve-
ments of the original split-ubiquitin protocol, together
with several selection steps to reduce potential false-
positive interactors. This easy-to-reproduce protocol was
tested to ﬁnd interactors of human Fz1, a protein that was
previously notoriously problematic to be used in Y2H
screens. After the systematic elemination of false-positive
interactors, 16 candidates were obtained.
DISCUSSION
Here we describe a systematic analysis of R-URA3p
reporter properties critical for the eﬃciency and robust-
ness of split-ubiquitin cDNA-library screening. One
unexpected ﬁnding testing a p53–PP5 model interaction
was that URA-deﬁcient cells are less sensitive for toxic
concentrations of 5-FOA if they expressed prey proteins
(compared to clones in which URA probably was
mutated). Therefore, in order to enhance the eﬃciency
of screening procedures, the optimal 5-FOA concentra-
tion needs to be thoroughly titrated for each individual
Figure 7. De-selection of false-positives resulting from mutations in
R-URA3p. To identify prey-plasmid independent URA3-auxotrophic
clones, passive prey-plasmid loss was induced. Clones were eventually
spotted onto medium lacking uracil (-uracil). After 48h incubation,
clones that failed to grow were excluded from further analyses. The
control plate contained uracil.
Figure 8. Positive phenotypic re-tests of isolated prey-plasmids.
Following prey-plasmid rescue, individual re-transformations of
s-Fz1-CRU bait and prey plasmids were performed. Duplicate clones
were spotted each in serial dilutions onto medium lacking uracil
(-URA), medium containing 5-FOA (+FOA), and control plates
selective for the presence of plasmids (C). Interaction is indicated by
lack-of-growth on –URA, paralleled by 5-FOA resistance. As negative
control served a clone co-transformed with s-Fz1-CRU and empty prey
vector (NubI). A previously identiﬁed bait construct with an inactive
URA3p phenocopying a true interaction event was also included.
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needs to be high enough to minimize non-speciﬁc back-
ground. On the other hand, we found that choosing
conditions that are too stringent strongly enriches for
false-positive hits derived from URA3-inactivation, prob-
ably as a consequence of spontaneous mutation events.
For a rapid identiﬁcation of this reporter-speciﬁc class
of false-positive preys, we have provided the protocol for
a simple phenotypic test that functions independently of
counter-selection for the prey plasmid. Both phenotypic
testing and counter-selection signiﬁcantly enhanced
the reliability of split-ubiquitin interactions screens, as
could be demonstrated recently in a number of cases
[reviewed in (28)].
We also provide evidence that the 5-FOA selection
conditions can be improved by lowering the density of
yeast cells plated after transformation. This, on the
other hand, requires the determination of transformation
eﬃciencies individually for each bait and library prior
to screening. A ﬂow chart describing individual steps of
improvement to enhance speed, reliability and ﬁdelity of
split-ubiquitin screens sums up our results (Figure 2).
In the second part of our experiments we have shown
the practicability of our improved protocol by identifying
proteins that are capable of interacting with Fz1.
Although the experimental placement of these proteins
in the signalling pathway of Fz1 is not the goal of this
manuscript, we would like to note that, with few excep-
tions, these have previously been described to act in Fz1-
associated pathways and therefore are good candidates
which could represent novel missing links of the pathway
(Figure 9; see also ‘Supplementary Information). For
example, a novel interaction between Fz1 and the guanine
nucleotide exchange factor GEFT was found (29). Rho
family GTPases were reported previously to play a role
in Drosophila PCP signalling, and Rho, Rac and Cdc42
take also part in vertebrate non-canonical Wnt signalling
[reviewed in (17)]. However, the precise mechanism of
activation of Rho family GTPases in Wnt signalling has
not yet been elucidated. It is well known that activation of
Rho family proteins requires the exchange of bound GDP
for GTP mediated by the Dbl family of guanine nucleotide
exchange factors (GEFs). GEFT has been described as
RhoA-speciﬁc GEF, which is however in conﬂict with an
earlier report suggesting Rac1 and Cdc42 speciﬁcity (30).
Our ﬁnding of a physical association of Frizzled1 and
GEFT may give a new hint on the mechanism of direct
signal transduction of Wnt to Rho family GTPases.
The proposed role of GEFT in the regulation of cell mor-
phology, cell proliferation, and transformation further
supports its potential role in Wnt-Fz signalling (30).
Additionally, in Xenopus laevis the related Rho guanine
nucleotide exchange factor xNET1 was found to physically
interact with the canonical Wnt Fz signalling component
Dishevelled (which itself is a Frizzled interactor), and has
been implicated in gastrulation movements (31).
Recently, a notochord expressed Rho-speciﬁc guanine
nucleotide exchange factor (notoGEF) was shown to have
a direct role in PCP-controlled gastrulation cell move-
ments (Kosuke Tanegashima and Igor Dawid, NIH;
personal communication).
With the exception of the Rab geranylgeranyltransfer-
ase a-subunit and b-adaptin other interactors found are
only poorly characterized and cannot be linked to the
Wnt/Fz1 pathway without additional experiments. There
are many questions remaining from the Fz1 screen that are
obviously not the main focus of this manuscript and need
to be addressed systematically elsewhere. However, we will
brieﬂy introduce the most prevailing issues since similar
questions will arise in any split-ubiquitin or related screen:
Why did we not isolate some of the published interactors,
whereas we identiﬁed a few interacting proteins that
cannot be easily explained based on the known functions
of Fz1. It needs to be noted that we did not identify in our
Table 1. Proteins identiﬁed as Frizzled1 interactors in the split-ubiquitin screen
Prey protein deﬁnition Accession Prey
full length
Nub-fusion
point
Pathway association with
Beta adaptin AAA40797 937 155 ?
Calmodulin 1 AAP36156 150 1 Wnt/Ca
2+ signaling
Fibronectin precursor CAA26536 2328 1218 Planar cell polarity+
Wnt/cAMP signaling
Histone deacetylase 5 AAD29047 1122 669 Canonical pathway
Hypothetical protein LOC54934 AAH13900 390 289 ?
LIM domain only 4 AAH03600 165 41 ?
Nesprin-1 AAN60442 8797 450 ?
Neurochondrin-2 BAA77831 712 546 Wnt/Ca
2+ signaling
Novel protein containing a tubulin-tyrosine
ligase family domain
CAI22724 553 1 ?
Nucleosome assembly protein BAA08904 506 77 ?
PEG3 AAC83176 615 414 ?
Rab geranylgeranyltransferase, alpha subunit NP_004572 567 354 ?
RAC/CDC42/Rho exchange factor GEFT AAO49463 580 206 Wnt/Rho signaling
Receptor-type protein tyrosine phosphatase beta,
RPTP beta, PTP zeta
AAB26530 2307 1447 Canonical pathway
Tubulin, beta, 2 AAH29529 445 1 Canonical pathway
Vac14 homolog NP_060522 782 183 ?
? refers to poorly characterized protein. Further experiments are needed to link it to Wnt pathway.
e37 Nucleic Acids Research, 2008, Vol. 36, No. 6 PAGE 10 OF13screen the following previously reported interactors of
Fz1: Wnt, Norrin, Dishevelled, PSD95, Kermit, GOPC,
MAGI3 (see http://www.stanford.edu/ rnusse/pathways/
binding.html). Diﬀerent reasons may account for this
ﬁnding. First, interactor binding to the ectodomain is
unlikely to work using the split-ubiquitin system, since the
ubiquitin domains would meet extracellularly, where the
protein degradation machinery is absent. Second, PDZ
domain proteins (including, e.g. Dishevelled, Kermit)
typically recognize the free C-terminal residues of their
targets that are not accessible due to the fusion with
the CRU domain. Third, both Wnt and Norrin are
Figure 9. Schematic representation of candidate interactors and their putative postion in the Frizzled signaling pathway. Frizzled-CRU bait and prey
proteins (shown in red) are indicated. Arrows with solid lines represent associations based on literature knowledge, dotted lines represent speculative
associations. Arrows marked with ‘B’ represents ‘physical interaction (binding)’. Abbreviations: APC, adenomatous polyposis of the colon; CaMKII,
calcium/calmodulindependent protein kinase II; cAMP, cyclic adenosine monophosphate; CREB, cAMP responsive element binding protein;
Dsh, Dishevelled; EGFR, epidermal growth factor receptor; FRIED, frizzled interaction and ectoderm development; GEFT, RAC/CDC42/Rho
exchange factor guanyl-nucleotide exchange factor; GSK3b, glycogen synthase kinase-3; HDAC, histone deacetylase; LEF/TCF, lymphoid enhancer
factor/T-cell transcription factor; notoGEF, Xenopus notochord expressed Rho-speciﬁc guanine nucleotide exchange factor; PKA, protein kinase A;
PKC, protein kinase C; Rac, ras-related C3 botulinum toxin substrate; Rho, Rho (Ras homology) subfamily of Ras-like small GTPases; RPTP,
receptor-type protein tyrosine phosphatase; Wnt, wingless-type MMTV integration site family member.
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larly, whereas Cub was fused to the C-terminal, intracel-
lular end of s-Fz1. Fourth, a low abundance of speciﬁc
mRNA in the non-normalized human fetal brain library
that was used may be a trivial explanation. Alternatively,
misfolding of the expressed interaction domains in the
yeast, or sterical interference with the ubiquitin or URA
domains, may force the interaction domain into an
incorrect structure. This would also result in problems
in any other screening system using tagged proteins or
protein fusions. Some of these issues could be overcome by
increasing the number of screened yeast clones, and/or by
using an alternatively constructed prey-plasmid library
using N-terminal fusions of cDNA inserts to Nub.
Surprisingly, we identiﬁed as a candidate interactor
an extracellular factor, the matrix protein ﬁbronectin.
A simple explanation would be that both proteins interact
during their transport through the ER and Golgi compart-
ment. In another example, the TM proteins presenilin,
Pen-2, nicastrin and Aph-1 of the g-secretase complex
involved in APP cleavage also interact ﬁrst in the ER to
become later localized to the cytoplasmic membrane (32).
Alternatively, the ﬁbronectin clone that was selected did
not represent a full length protein, suggesting that this
protein fragment could have been mislocated to the
interior of the cell, where it interacts with the predicted
extracellular part of Fz1. It is not known at present, but
cannot be excluded, that a subfraction of s-Fz1-CRU,
either as a consequence of its synthetic secretion signal,
the CRU domain, or as part of its biological role, may
also be localized to the cytoplasm. Futher experiments will
be required to solve these issues.
Clearly, the potential novel Fz1 interactors need further
functional validation which can be achieved by a combi-
nation of diﬀerent experimental approaches. Physical
interaction may ﬁrst be conﬁrmed by a complementary
biochemical approach such as co-immunoprecipitation.
In vitro functional validation methods may include cell
culture-based reporter gene assays speciﬁc for signalling
phenomena, such as the TOP ﬂash assay for canonical
signalling (20,21). Typically, in such assays functional
interactions can be monitored by measuring reporter
gene expression following the activation/inactivation
of signalling components. Furthermore, interactions can
be validated using suitable model organisms (such as
Drosophila, Xenopus or C. elegans) that encode homologs
of the Wnt-Fz signal transduction cascade.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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